Arch Therapeutics, Inc. (OTCMKTS:ARTH – Get Free Report)’s share price crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $1.60 and traded as low as $0.98. Arch Therapeutics shares last traded at $1.04, with a volume of 408 shares trading hands.
Arch Therapeutics Stock Performance
The company’s 50 day moving average price is $1.60 and its two-hundred day moving average price is $3.31.
Arch Therapeutics (OTCMKTS:ARTH – Get Free Report) last posted its quarterly earnings results on Tuesday, February 20th. The biotechnology company reported ($0.57) earnings per share for the quarter. The firm had revenue of $0.05 million for the quarter.
Arch Therapeutics Company Profile
Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.
Recommended Stories
- Five stocks we like better than Arch Therapeutics
- CD Calculator: Certificate of Deposit Calculator
- Roblox: The Bottom Just Fell Out of the Metaverse
- Stock Dividend Cuts Happen Are You Ready?
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- Consumer Discretionary Stocks Explained
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for Arch Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
